Business Description
Farmacias Benavides SAB de CV
SIC : 2834
ISIN : MXP3895X1106
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | 0.05 | |||||
Debt-to-Equity | 8.06 | |||||
Debt-to-EBITDA | 1.84 | |||||
Interest Coverage | 2.07 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.52 | |||||
Beneish M-Score | -1.77 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.5 | |||||
3-Year EBITDA Growth Rate | 18.5 | |||||
3-Year FCF Growth Rate | -7.1 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 3.05 | |||||
14-Day RSI | 36.84 | |||||
6-1 Month Momentum % | 5.82 | |||||
12-1 Month Momentum % | 6.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.92 | |||||
Quick Ratio | 0.34 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 90.66 | |||||
Days Sales Outstanding | 2.33 | |||||
Days Payable | 104.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -3.41 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.74 | |||||
Operating Margin % | 4.97 | |||||
Net Margin % | 1.64 | |||||
FCF Margin % | 3.83 | |||||
ROE % | 94.14 | |||||
ROA % | 3.34 | |||||
ROIC % | 11.43 | |||||
3-Year ROIIC % | -24.23 | |||||
ROC (Joel Greenblatt) % | 26.39 | |||||
ROCE % | 25.9 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 21.7 | |||||
PE Ratio without NRI | 21.7 | |||||
Price-to-Owner-Earnings | 6.03 | |||||
PEG Ratio | 0.29 | |||||
PS Ratio | 0.36 | |||||
PB Ratio | 14.65 | |||||
Price-to-Tangible-Book | 16.25 | |||||
Price-to-Free-Cash-Flow | 9.29 | |||||
Price-to-Operating-Cash-Flow | 6.79 | |||||
EV-to-EBIT | 10.16 | |||||
EV-to-EBITDA | 4.71 | |||||
EV-to-Revenue | 0.5 | |||||
EV-to-FCF | 13.1 | |||||
Price-to-Projected-FCF | 2.63 | |||||
Price-to-Median-PS-Value | 0.8 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.87 | |||||
Price-to-Graham-Number | 3.97 | |||||
Earnings Yield (Greenblatt) % | 9.84 | |||||
FCF Yield % | 11.1 | |||||
Forward Rate of Return (Yacktman) % | 27.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Farmacias Benavides SAB de CV Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 17,226.004 | ||
EPS (TTM) (MXN) | 0.691 | ||
Beta | -0.01 | ||
Volatility % | 4.43 | ||
14-Day RSI | 36.84 | ||
14-Day ATR (MXN) | 0.000906 | ||
20-Day SMA (MXN) | 19.998 | ||
12-1 Month Momentum % | 6.55 | ||
52-Week Range (MXN) | 18.57 - 20 | ||
Shares Outstanding (Mil) | 408.84 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Farmacias Benavides SAB de CV Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Farmacias Benavides SAB de CV Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Farmacias Benavides SAB de CV Frequently Asked Questions
What is Farmacias Benavides SAB de CV(MEX:BEVIDESB)'s stock price today?
When is next earnings date of Farmacias Benavides SAB de CV(MEX:BEVIDESB)?
Does Farmacias Benavides SAB de CV(MEX:BEVIDESB) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |